| Literature DB >> 18687492 |
Elif Eroglu, Gokmen Gemici, Fatih Bayrak, Ali Kemal Kalkan, Muzaffer Degertekin.
Abstract
Sibutramine is an anti-obesity drug, which acts by inhibiting neuronal re-uptake of noradrenaline and serotonin. Although the most frequently seen effect of sibutramine on cardiovascular system is an increase in blood pressure and pulse rate, rare but severe side effects such as sibutramine-induced ventricular arrhythmias, heart failure and cardiovascular disease-related death are also reported. We describe a 24 year-old man with low atherosclerotic risk profile who had acute myocardial infarction possibly associated with sibutramine use.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18687492 DOI： 10.1016/j.ijcard.2008.06.017
Source DB: PubMed Journal: Int J Cardiol ISSN： 0167-5273 Impact factor: 4.164